Found 7 matching trials
Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate PHASE2 The purpose of this study is to evaluate the immunogenicity and the safety ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate PHASE2 The purpose of this phase IIb study is to demonstrate the consistency of th...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study to Evaluate an Influenza Vaccine Candidate PHASE2 In order to find the formulation leading to a maximal increase of the immun...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate PHASE2 The purpose of this study is to evaluate the immunogenicity and the safety ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study to Evaluate an Influenza Vaccine Candidate PHASE2 The purpose of this study is to evaluate the immune response and safety of ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate PHASE2 The purpose of this study is to evaluate the immunogenicity and the safety ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Revaccination With Influenza Vaccine GSK1247446A PHASE2 The protocol is designed to demonstrate the safety of influenza vaccine GSK...
Show More Location
GSK Investigational Site
Learn More & Join Trial